The regulation of the JAK2-STAT3 pathway by Chemerin/CMKLR1 can augment autophagy and ameliorate hepatic oxidative stress, thereby enhancing NASH. Here, CMKLR1 is linked to metabolic dysfunction-associated steatohepatitis.